142 related articles for article (PubMed ID: 30667054)
1. BRG1 is a prognostic indicator and a potential therapeutic target for prostate cancer.
Muthuswami R; Bailey L; Rakesh R; Imbalzano AN; Nickerson JA; Hockensmith JW
J Cell Physiol; 2019 Sep; 234(9):15194-15205. PubMed ID: 30667054
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
Papillon JPN; Nakajima K; Adair CD; Hempel J; Jouk AO; Karki RG; Mathieu S; Möbitz H; Ntaganda R; Smith T; Visser M; Hill SE; Hurtado FK; Chenail G; Bhang HC; Bric A; Xiang K; Bushold G; Gilbert T; Vattay A; Dooley J; Costa EA; Park I; Li A; Farley D; Lounkine E; Yue QK; Xie X; Zhu X; Kulathila R; King D; Hu T; Vulic K; Cantwell J; Luu C; Jagani Z
J Med Chem; 2018 Nov; 61(22):10155-10172. PubMed ID: 30339381
[TBL] [Abstract][Full Text] [Related]
3. SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice.
Wiley MM; Muthukumar V; Griffin TM; Griffin CT
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25904594
[TBL] [Abstract][Full Text] [Related]
4. The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer.
Wu Q; Lian JB; Stein JL; Stein GS; Nickerson JA; Imbalzano AN
Epigenomics; 2017 Jun; 9(6):919-931. PubMed ID: 28521512
[TBL] [Abstract][Full Text] [Related]
5. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
[TBL] [Abstract][Full Text] [Related]
6. BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
Wu S; Ge Y; Huang L; Liu H; Xue Y; Zhao Y
Cell Cycle; 2014; 13(18):2869-78. PubMed ID: 25486475
[TBL] [Abstract][Full Text] [Related]
7. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
9. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
Padilla-Benavides T; Nasipak BT; Paskavitz AL; Haokip DT; Schnabl JM; Nickerson JA; Imbalzano AN
J Biol Chem; 2017 Nov; 292(45):18592-18607. PubMed ID: 28939766
[TBL] [Abstract][Full Text] [Related]
10. Chromatin remodeling enzyme Brg1 is required for mouse lens fiber cell terminal differentiation and its denucleation.
He S; Pirity MK; Wang WL; Wolf L; Chauhan BK; Cveklova K; Tamm ER; Ashery-Padan R; Metzger D; Nakai A; Chambon P; Zavadil J; Cvekl A
Epigenetics Chromatin; 2010 Nov; 3(1):21. PubMed ID: 21118511
[TBL] [Abstract][Full Text] [Related]
11. Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer.
Ailiken G; Kitamura K; Hoshino T; Satoh M; Tanaka N; Minamoto T; Rahmutulla B; Kobayashi S; Kano M; Tanaka T; Kaneda A; Nomura F; Matsubara H; Matsushita K
Oncogenesis; 2020 Feb; 9(2):26. PubMed ID: 32071290
[TBL] [Abstract][Full Text] [Related]
12. Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
Rago F; Rodrigues LU; Bonney M; Sprouffske K; Kurth E; Elliott G; Ambrose J; Aspesi P; Oborski J; Chen JT; McDonald ER; Mapa FA; Ruddy DA; Kauffmann A; Abrams T; Bhang HC; Jagani Z
Mol Cancer Res; 2022 Mar; 20(3):361-372. PubMed ID: 34799403
[TBL] [Abstract][Full Text] [Related]
13. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
[TBL] [Abstract][Full Text] [Related]
14. Cdx2 Regulates Gene Expression through Recruitment of Brg1-associated Switch-Sucrose Non-fermentable (SWI-SNF) Chromatin Remodeling Activity.
Nguyen TT; Savory JGA; Brooke-Bisschop T; Ringuette R; Foley T; Hess BL; Mulatz KJ; Trinkle-Mulcahy L; Lohnes D
J Biol Chem; 2017 Feb; 292(8):3389-3399. PubMed ID: 28082674
[TBL] [Abstract][Full Text] [Related]
15. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
[TBL] [Abstract][Full Text] [Related]
16. Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells.
Wu Q; Sharma S; Cui H; LeBlanc SE; Zhang H; Muthuswami R; Nickerson JA; Imbalzano AN
Oncotarget; 2016 May; 7(19):27158-75. PubMed ID: 27029062
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP; Sanchez-Cespedes M
Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
[TBL] [Abstract][Full Text] [Related]
18. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
Raab JR; Runge JS; Spear CC; Magnuson T
Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
[TBL] [Abstract][Full Text] [Related]
19. The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.
Sharma T; Robinson DCL; Witwicka H; Dilworth FJ; Imbalzano AN
Nucleic Acids Res; 2021 Aug; 49(14):8060-8077. PubMed ID: 34289068
[TBL] [Abstract][Full Text] [Related]
20. Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.
Hoffman GR; Rahal R; Buxton F; Xiang K; McAllister G; Frias E; Bagdasarian L; Huber J; Lindeman A; Chen D; Romero R; Ramadan N; Phadke T; Haas K; Jaskelioff M; Wilson BG; Meyer MJ; Saenz-Vash V; Zhai H; Myer VE; Porter JA; Keen N; McLaughlin ME; Mickanin C; Roberts CW; Stegmeier F; Jagani Z
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3128-33. PubMed ID: 24520176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
